Mutz Christopher

HEAD OF RARE DISEASE

Mutz Christopher has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Mar 13, 2026.

On the most recent filing, Mutz Christopher is listed as HEAD OF RARE DISEASE at ANI PHARMACEUTICALS INC. Inside the rolling window, Mutz Christopher reported no open-market purchases and 6 open-market sales totaling $1.6M in ANIP. The largest disclosed transaction in the window is a sale of 7,032 ANIP shares on Feb 12, 2026, worth $538K.

Companies traded

Other insiders at ANIP

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.6M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ANIPSale$227KMar 13SEC ↗
ANIPSale$157KMar 10SEC ↗
ANIPSale$267KMar 10SEC ↗
ANIPSale$31KMar 4SEC ↗
ANIPSale$415KFeb 23SEC ↗
ANIPSale$538KFeb 17SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Mutz Christopher made?

Mutz Christopher has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company since 2026.

Which companies does Mutz Christopher trade?

Mutz Christopher has filed SEC Form 4 disclosures for 1 company, including ANIP.

When was Mutz Christopher's most recent SEC Form 4 filing?

Mutz Christopher's most recent SEC Form 4 filing on Tracefour is dated Mar 13, 2026.

What is Mutz Christopher's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Mutz Christopher is listed as HEAD OF RARE DISEASE.

What is Mutz Christopher's total buy and sell value in the current window?

Inside the rolling retention window, Mutz Christopher bought $0 and sold $1.6M based on SEC Form 4 filings.

What was Mutz Christopher's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 7,032 ANIP shares on 2026-02-12, worth $538K, per SEC Form 4 filings.